title: [Transport of large organic ions through syringomycin channels in the membranes containing dipole modifiers].
abstract: The effect of the membrane dipole potential (Phid) on a conductance and a steady-state number of functioning channels formed by cyclic lipodepsipeptide syringomycin E (SRE) in bilayer lipid membranes made from phosphocholine and bathed in 0.4 M solution of sodium salts of aspartate, gluconate and chloride was shown. The magnitude of Phid was varied with the introduction to membrane bathing solutions of phloretin, which reduces the Phid, and RH 421, increasing the Phid. It was established that in all studied systems the increase in the membrane dipole potential cause a decrease in the steady-state number of open channels. In the systems containing sodium salts of aspartate (Asp) or gluconate (Glc), changes in the number of functioning channels are in an order of magnitude smaller than in systems containing sodium chloride. At the same time, the conductance (g) of single SRE-channels on the membranes bathed in NaCI solution increases with the increase in Phid, and in the systems containing NaAsp or NaGlc the conductance of single channels does not depend on the Phid. The latter is due to the lack of cation/anion selectivity of the SRE-channels in these systems. The different channel-forming activity of SRE in the experimental systems is defined by the gating charge of the channel and the partition coefficient of the dipole modifiers between the lipid and aqueous phases.
authors.forename: S S
authors.initials: SS
authors.lastname: Efimova
authors.forename: O S
authors.initials: OS
authors.lastname: Ostroumova
authors.forename: V V
authors.initials: VV
authors.lastname: Malev
authors.forename: L V
authors.initials: LV
authors.lastname: Shchagina
mesh_terms: D000838:Anions / Q000378:metabolism; D000935:Antifungal Agents / Q000378:metabolism* / Q000494:pharmacology; D001224:Aspartic Acid / Q000378:metabolism; D001692:Biological Transport / Q000187:drug effects; D002412:Cations / Q000378:metabolism; D004553:Electric Conductivity; D005942:Gluconates / Q000378:metabolism; D007473:Ion Channels / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D008051:Lipid Bilayers / Q000737:chemistry / Q000378:metabolism*; D008564:Membrane Potentials / Q000187:drug effects; D008567:Membranes, Artificial; D010456:Peptides, Cyclic / Q000378:metabolism* / Q000494:pharmacology; D010693:Phloretin / Q000494:pharmacology; D010713:Phosphatidylcholines / Q000737:chemistry / Q000378:metabolism; D011726:Pyridinium Compounds / Q000494:pharmacology; D012965:Sodium Chloride / Q000378:metabolism; D055672:Static Electricity; D013343:Styrenes / Q000494:pharmacology
chemical_list: D000838:Anions; D000935:Antifungal Agents; D002412:Cations; D005942:Gluconates; D007473:Ion Channels; D008051:Lipid Bilayers; D008567:Membranes, Artificial; D010456:Peptides, Cyclic; D010713:Phosphatidylcholines; D011726:Pyridinium Compounds; D013343:Styrenes; C070534:RH 421; C105246:syringomycin E; D001224:Aspartic Acid; D012965:Sodium Chloride; C030691:gluconic acid; D010693:Phloretin